TY - JOUR T1 - Introduction JF - Tobacco Control JO - Tob Control SP - S44 LP - S44 DO - 10.1136/tc.4.suppl2.S44 VL - 4 IS - Suppl 2 AU - John R Hughes Y1 - 1995/09/01 UR - http://tobaccocontrol.bmj.com/content/4/Suppl_2/S44.1.abstract N2 - Our next presenters will be discussing several of the implications of the different kinds of harm reduction. Then we shall have the reactions of our panelists. Let me introduce our presenters and panelists.Our first presenter is Neal L Benowitz who is going to talk about medical implications of harm reduction. Dr Benowitz is professor of medicine, psychiatry, and pharmacology and chief of the division of clinical pharmacology and experimental therapeutics at the University of California-San Francisco. His research has focused primarily on human pharmacology and toxicology of nicotine.Our next speaker is Judith … ER -